483
ST Pharm Co., Ltd.ST Pharm Co., Ltd. – FDA 483, Nov 8, 2024
Record Details
ST Pharm Co., Ltd., an API manufacturer in Siheung-si, Gyeonggi-do, Korea, was cited for significant deficiencies during an FDA inspection. Observations included a lack of written quality agreements for contract testing and stability studies, inadequate validation of test methods for API purity, and poor document control practices. Additionally, the firm failed to adhere to its own GMP training effectiveness procedures.
View Company Profile
ID · 0b2012b9-06d4-479d-a65c-d5bbdbbd4577
Other documents for ST Pharm Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.